Biotech Startups
9,911 companies tagged Biotech, with their investors and founders.
2 investors
Aitiologic is a molecular diagnostics and precision medicine company that uses AI-powered bioinformatics to translate disease biology into clinical insight. It operates in the biotech and diagnostics space.
2 investors
Ajax Therapeutics is a biotech company developing Type II JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis, using computational chemistry and structural biology in its drug discovery. Its lead candidate, AJ1-11095, is in a Phase 1 clinical trial for patients who have failed currently available Type I JAK2 inhibitors.
2 investors
Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.
2 investors
Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.
2 investors
2 investors
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility. The company focuses on pet-focused biotechnology aimed at making animal therapies more affordable for pet owners.
2 investors
A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.
2 investors
Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.
2 investors
Alden Scientific is a biotech company with over 40 scientists, bioinformaticians, engineers, clinicians, and researchers developing immunological research capabilities. The company operates across Cambridge, Massachusetts and Dortmund, Germany.
2 investors
2 investors
Aldevron provides products and services for biotechnology research and life sciences discovery, operating as a subsidiary of Danaher to enable breakthrough scientific advances.
2 investors
Alethia Biotherapeutics is a clinical-stage biotechnology company developing cancer treatments that target tumor resistance by inhibiting the epithelial-mesenchymal transition (EMT) and remodeling the immunosuppressive tumor microenvironment. Its lead asset, sotevtamab, is a monoclonal antibody intended to be combined with standard therapies across multiple cancer indications.
2 investors
Alexza Pharmaceuticals, now operating as Nova Pneuma, Inc., is a pharmaceutical company that developed the Staccato One Breath Technology drug-delivery platform and markets the commercial product Adasuve. Its Staccato platform and assets were acquired by Lee's Pharmaceutical Holdings.
2 investors
AlgaleX produces "Umamo," an umami-rich microalgae (Aurantiochytrium) cultivated by fermenting unused food resources such as discarded awamori lees, yielding a natural DHA-rich flavor ingredient sold as an alternative to kombu and bonito. Founded by a former trading company businessperson and University of Tsukuba academics, the company develops algae fermentation technology aimed at supplying protein and omega-3 nutrients without depleting fish stocks, operating from Okinawa, Japan.
2 investors
Alia Therapeutics is a biotech company developing therapeutics based on gene-editing technology.
2 investors
Aligned Bio develops nanowire-based biosensor platforms capable of detecting single molecules, serving customers in diagnostic and research applications. The company manufactures advanced sensors using proprietary methods for organizing and functionalizing nanowires on various substrates.
2 investors
Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.
2 investors
Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
2 investors
All G produces high-value proteins using precision fermentation technology for infant formula, dietary supplements, and personal care applications. The company manufactures lactoferrin and human milk proteins at scale while maintaining infant formula-grade purity and quality standards for global markets.
2 investors
Allevi, part of 3D Systems, makes desktop 3D bioprinters and bioinks used by academic and industry research labs to design and engineer 3D tissues. Its tools support work in regenerative medicine, drug testing, and disease research.
2 investors
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
2 investors
Allium Bio develops a co-culturing system that grows multiple species—such as algae, fungi, and yeasts—together to produce food ingredients that combine their nutritional properties like proteins, fats, and vitamins. The company aims to design sustainable co-cultured ingredients for the food industry using faster modeling in place of lengthy research.
2 investors
Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
2 investors